Addition of exogenous cytokines in mixed lymphocyte culture for selecting related donors for bone marrow transplantation
Keywords:
Mixed lymphocyte culture, Bone marrow transplantation, Cytokines, Graft-versus-host diseaseAbstract
CONTEXT: Mixed lymphocyte culturing has led to conflicting opinions regarding the selection of donors for bone marrow transplantation. The association between a positive mixed lymphocyte culture and the development of graft-versus-host disease (GVHD) is unclear. The use of exogenous cytokines in mixed lymphocyte cultures could be an alternative for increasing the sensitivity of culture tests. OBJECTIVE: To increase the sensitivity of mixed lymphocyte cultures between donor and recipient human leukocyte antigen (HLA) identical siblings, using exogenous cytokines, in order to predict post-transplantation GVHD and/or rejection. TYPE OF STUDY: Prospective study. SETTING: Bone Marrow Transplantation Unit, Universidade Estadual de Campinas. PARTICIPANTS: Seventeen patients with hematological malignancies and their respective donors selected for bone marrow transplantation procedures. PROCEDURES: Standard and modified mixed lymphocyte culturing by cytokine supplementation was carried out using donor and recipient cells typed for HLA. MAIN MEASUREMENTS: Autologous and allogenic responses in mixed lymphocyte cultures after the addition of IL-4 or IL-2. RESULTS: In comparison with the standard method, average responses in the modified mixed lymphocyte cultures increased by a factor of 2.0 using IL-4 (p < 0.001) and 6.4 using IL-2 (p < 0.001), for autologous donor culture responses. For donor-versus-recipient culture responses, the increase was by a factor of 1.9 using IL-4 (p < 0.001) and 4.1 using IL-2 (p < 0.001). For donor-versus-unrelated culture responses, no significant increase was observed using IL-4, and a mean response inhibition of 20% was observed using IL-2 (p < 0.001). Neither of the cytokines produced a significant difference in the unrelated control versus recipient cell responses. CONCLUSION: IL-4 supplementation was the best for increasing the mixed lymphocyte culture sensitivity. However, IL-4 also increased autologous responses, albeit less intensively than IL-2. Thus, with this loss of specificity we believe that it is not worth modifying the traditional mixed lymphocyte culture method, even with IL-4 addition.
Downloads
References
Bach FH, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964;143:813-14.
Visentainer JEL, Lieber SR, Persoli LBL, et al. Correlation of mixed lymphocyte culture with chronic graft-versus-host dis- ease following allogenic stem cell transplantation. Braz J Med Biol Res 2002;35:567-72.
Yokota T, Otsuka, T, Mosmann, T, et al. Isolation and charac- terization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T- cell-stimulating activities. Proc Natl Acad Sci USA 1986;83:5894-8.
Severinson E, Naito T, Tokumoto H, et al. Interleukin 4 (IgG1 induction factor): a multifunctional lymphokine acting also on
T cells. Eur J Immunol 1987;17:67-72.
Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987;56:727-77.
Virelizier JL, Perez N, Arenzana-Seisdedos F, Devos R. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines. Eur J Immunol 1984;14:106-8.
Smith KA. T-cell growth factor. Immunol Rev 1980;51:337- 57.
Mickelson EM, Guthrie LA, Hansen JA. The mixed lymphocyte culture (MLC) test. In: Land G, Strothman R, editors. ASHI Laboratory Manual. New York, NY: The American Society for Histocompatibility and Immunogenetics; 2000.
Bishara A, Brautbar C, Nagler A, et al. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogenic bone marrow transplantation. Transplantation 1994;57:1474-9.
Gerrard TL, Dyer DR, Zoon KC, zur Nedden D, Siegel JP. Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma. J Immunol 1988;140:3450-5.
Perola O, Ripatti A, Pelkonen J. T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation. Scand J Immunol 2000;52:123-30.
Degiannis D, Czarnecki M, Hornung N, Raskova J, Raska K. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor. Transplantation 1991;51:518-23.
Danzer SG, Kirchner H, Rink L. Cytokine interactions in human mixed lymphocyte culture. Transplantation 1994;57:1638-42.
